Aigen Investment Management, LP Galapagos Nv Transaction History

Aigen Investment Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$36.5 - $48.0 $402,850 - $529,776	11,037 New	11,037 $426,000
Q3 2021 Nov 12, 2021	SELL	$52.17 - $70.2 $258,919 - $348,402	-4,963 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$68.86 - $83.34 $341,752 - $413,616	4,963 New	4,963 $342,000
Q4 2020 Feb 12, 2021	SELL	$96.85 - $148.25 $1.61 Million - $2.46 Million	-16,592 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$122.47 - $213.56 $1.12 Million - $1.95 Million	9,148 Added 122.89%	16,592 $2.36 Million
Q2 2020 Aug 10, 2020	BUY	$185.52 - $231.25 $1.09 Million - $1.36 Million	5,861 Added 370.25%	7,444 $1.47 Million
Q1 2020 May 08, 2020	BUY	$143.0 - $274.03 $226,369 - $433,789	1,583 New	1,583 $310,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.58B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.